DELTA HEALTH-NORTHWEST REGIONAL
1. Target Overview & Investment Thesis
DELTA HEALTH-NORTHWEST REGIONAL is a 174-bed safety-net/medicaid heavy in COAHOMA, MS with $31.0M in net patient revenue and a -30.8% operating margin. The hospital serves a payer mix of 18.6% Medicare, 46.1% Medicaid, and 35.3% commercial.
Thesis: Undervalued. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -30.8% to -23.4% (+736bps).
| Net Revenue HCRIS | $31.0M |
| Current EBITDA COMPUTED | $-9.5M |
| Operating Margin COMPUTED | -30.8% |
| Occupancy HCRIS | 10.2% |
| Revenue / Bed COMPUTED | $178K |
| Net-to-Gross HCRIS | 15.1% |
| Distress Probability ML | 66.9% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -30.8% places it below the state median. Among 26 size-comparable peers (87-348 beds), the median margin is -4.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (87-348), prioritizing same-state peers. 26 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DELTA HEALTH-NORTHWEST REGIONA (Target) | MS | 174 | $31.0M | -30.8% |
| MEMORIAL HOSPITAL AT GULFPORT | MS | 278 | $700.2M | -15.7% |
| SINGING RIVER HEALTH SYSTEM | MS | 294 | $415.9M | -12.8% |
| BAPTIST MEM HOSPITAL DESOTO | MS | 298 | $301.6M | -5.2% |
| BAPTIST MEM HOSPITAL NORTH MIS | MS | 195 | $229.4M | 0.7% |
| BAPTIST MEM HOSPITAL GOLDEN TR | MS | 154 | $221.1M | 6.9% |
| JEFF ANDERSON REGIONAL MEDICAL | MS | 270 | $213.3M | -25.9% |
| MAGNOLIA HOSPITAL | MS | 158 | $161.6M | -4.7% |
| SOUTH CENTRAL REGIONAL MEDICAL | MS | 268 | $146.9M | -1.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $651K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $620K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $614K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $377K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $20K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-9.5M |
| + RCM Uplift | +$2.3M |
| Pro Forma EBITDA | $-7.3M |
| Current Margin | -30.8% |
| Pro Forma Margin | -23.4% |
| WC Released (1x) | $1.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-14.7M | $-40.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-14.7M | $-48.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-13.2M | $-46.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-13.2M | $-54.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-16.1M | $-46.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-16.1M | $-56.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (46.1%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 10.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 66.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 26 hospitals with 87-348 beds
- Same-state prioritization (n=27)
- Comp margins: P25=-15.7% / P50=-4.7% / P75=1.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.